What's the Fermenta Biotech share price today?

As on 22 Jun, 2026, 03:46 PM IST Fermenta Biotech share price is up by 1.61% basis the previous closing price of Rs 318.8. Fermenta Biotech share price is Rs 342.60.

What is the market cap of Fermenta Biotech?

Within the Pharmaceuticals sector, Fermenta Biotech stock has a market cap rank of 90. Fermenta Biotech has a market cap of Rs 1,008.31 Cr.

What is the PE & PB ratio of Fermenta Biotech?

The PE ratio of Fermenta Biotech stands at 13.67, while the PB ratio is 2.41.

What has been highest price of Fermenta Biotech share in last 52 weeks?

In last 52 weeks Fermenta Biotech share had a high price of Rs 356.85 and low price of Rs 248.85

Fermenta Biotech Share Price

342.605.41 (1.61%)

Closed
As On: 22 Jun, 2026, 03:46 PM IST
As On: 22 Jun, 2026, 03:45 PM IST

Sector: Pharmaceuticals
Industry: Pharma - Indian

STOCK SCORE

Unlock Scores

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Try ETMarkets GPTNEW

Open	338.00
High	348.00
Low	334.05
Prev Close	337.20
Volume	79,759
VWAP(₹)	341.09

Share Price	Value
Today/Current/Last	342.60342.00
Previous Day	337.20338.20

Fermenta Biotech Share Recommendations

No Recommendations details available for this stock.
Check out other stock recos.

News & Analysis

Fermenta Biotech, Stallion India among 10 smallcaps jumped up to 27% in just 5 days. Did you own?
News
Last date to buy today! Grasim Industries among 12 stocks to trade ex-dividend on Tuesday
News
Sensex falls! These stocks fell 5% or more in Friday's session
News
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcements

View all Fermenta Biotech Share News & Announcements

Share Analysis

EARNINGS

FUNDAMENTAL

RELATIVE VALUATION

RISK

PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

Score on 10-point scale
Ratings by analysts
Stock performance

JOIN ET PRIME

Financials

Income (P&L)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	126.65	140.48	135.66	145.03	143.74
Total Income Growth (%)	-9.85	3.55	-6.47	0.90	-9.42
Total Expenses	97.62	119.96	108.99	113.84	108.77
Total Expenses Growth (%)	-18.63	10.07	-4.26	4.66	-0.47
EBIT	29.03	20.51	26.66	31.19	34.97
EBIT Growth (%)	41.50	-23.06	-14.52	-10.81	-29.23
Profit after Tax (PAT)	19.19	12.68	18.88	21.83	34.39
PAT Growth (%)	51.34	-32.83	-13.54	-36.51	-6.83
EBIT Margin (%)	22.92	14.60	19.65	21.51	24.33
Net Profit Margin (%)	15.15	9.03	13.92	15.06	23.92
Basic EPS (₹)	6.66	4.36	6.48	7.49	11.79

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	115.98	117.67	112.64	127.86	125.92
Total Income Growth (%)	-1.44	4.47	-11.90	1.54	-15.19
Total Expenses	84.05	98.06	89.28	102.04	94.96
Total Expenses Growth (%)	-14.29	9.83	-12.50	7.45	-6.84
EBIT	31.93	19.62	23.36	25.82	30.96
EBIT Growth (%)	62.75	-16.03	-9.54	-16.59	-33.48
Profit after Tax (PAT)	21.57	11.76	14.72	16.23	29.31
PAT Growth (%)	83.45	-20.10	-9.34	-44.62	-16.25
EBIT Margin (%)	27.53	16.67	20.74	20.20	24.59
Net Profit Margin (%)	18.60	9.99	13.07	12.70	23.28
Basic EPS (₹)	7.49	4.04	5.05	5.57	10.05

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	547.81	481.30	347.47	357.64	406.65
Total Revenue Growth (%)	13.82	38.51	-2.84	-12.05	5.48
Total Expenses	458.83	398.09	349.92	381.03	379.71
Total Expenses Growth (%)	15.26	13.77	-8.17	0.35	13.72
Profit after Tax (PAT)	72.58	76.86	-23.06	-51.50	15.45
PAT Growth (%)	-5.57	-	-	-433.38	-66.06
Operating Profit Margin (%)	19.13	20.74	4.34	-0.74	11.04
Net Profit Margin (%)	13.81	16.37	-6.86	-14.71	3.87
Basic EPS (₹)	24.70	26.35	-7.99	-17.85	5.33

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	474.15	442.21	315.24	336.48	395.49
Total Revenue Growth (%)	7.22	40.28	-6.31	-14.92	4.23
Total Expenses	391.88	367.79	310.85	335.58	352.92
Total Expenses Growth (%)	6.55	18.32	-7.37	-4.91	11.61
Profit after Tax (PAT)	64.28	67.62	-18.74	-57.53	30.24
PAT Growth (%)	-4.93	-	-	-290.27	-41.82
Operating Profit Margin (%)	20.82	20.58	6.98	6.64	15.41
Net Profit Margin (%)	14.27	15.70	-6.10	-17.49	7.79
Basic EPS (₹)	22.13	23.18	-6.49	-19.94	10.48

All figures in Rs Cr, unless mentioned otherwise

Insights

Employee & Interest Expense
Company has spent 2.2% of its operating revenues towards interest expenses and 15.72% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)

View Details

Balance Sheet

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	647.94	614.48	547.83	635.81	706.84
Total Assets Growth (%)	5.45	12.17	-13.84	-10.05	2.88
Total Liabilities	247.39	255.96	262.67	323.92	335.39
Total Liabilities Growth (%)	-3.35	-2.55	-18.91	-3.42	2.63
Total Equity	400.55	358.52	285.16	311.89	371.45
Total Equity Growth (%)	11.72	25.72	-8.57	-16.04	3.10
Current Ratio (x)	1.86	1.58	1.40	1.21	1.52
Total Debt to Equity (x)	0.27	0.30	0.46	0.69	0.63
Contingent Liabilities	0.00	6.81	2.12	27.64	26.35

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	652.36	622.47	564.58	664.66	712.65
Total Assets Growth (%)	4.80	10.25	-15.06	-6.73	4.41
Total Liabilities	229.54	242.51	250.35	330.59	316.67
Total Liabilities Growth (%)	-5.35	-3.13	-24.27	4.40	1.47
Total Equity	422.82	379.95	314.23	334.07	395.97
Total Equity Growth (%)	11.28	20.91	-5.94	-15.63	6.89
Current Ratio (x)	1.88	1.62	1.48	1.19	1.69
Total Debt to Equity (x)	0.26	0.29	0.42	0.65	0.60
Contingent Liabilities	0.00	9.83	5.13	30.65	29.37

All figures in Rs Cr, unless mentioned otherwise

View Details

Cash Flows

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	92.83	40.90	105.35	116.70	43.44
Net Cash used in Investing Activities	-43.00	-0.16	-15.50	-56.32	-26.04
Net Cash flow from Financing Activities	-42.29	-50.87	-90.85	-40.79	-21.58
Net Cash Flow	7.55	-10.12	-1.00	19.59	-4.17
Closing Cash & Cash Equivalent	14.18	6.63	16.75	17.71	-1.88
Closing Cash & Cash Equivalent Growth (%)	113.89	-60.43	-5.39	-1,040.04	-182.20
Total Debt/ CFO (x)	1.17	2.67	1.26	1.86	5.44

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	82.63	33.83	105.02	124.46	50.41
Net Cash used in Investing Activities	-44.50	0.41	-15.15	-64.44	-32.46
Net Cash flow from Financing Activities	-42.15	-50.91	-90.86	-40.80	-21.76
Net Cash Flow	-4.02	-16.67	-0.98	19.22	-3.81
Closing Cash & Cash Equivalent	-8.64	-3.12	13.56	14.47	-4.75
Closing Cash & Cash Equivalent Growth (%)	177.18	-122.99	-6.34	-404.90	406.44
Total Debt/ CFO (x)	1.32	3.23	1.26	1.74	4.68

All figures in Rs Cr, unless mentioned otherwise

Insights

Increase in Cash from Investing
Company has used Rs 43.0 cr for investing activities which is an YoY increase of 26856.93%. (Source: Consolidated Financials)

View Details

Ratios

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	17.86	21.19	-7.98	-16.36	4.15
Return on Capital Employed (%)	22.88	24.19	3.89	-0.61	8.81
Return on Assets (%)	11.20	12.50	-4.20	-8.09	2.18
Interest Coverage Ratio (x)	10.59	8.57	2.31	1.23	4.07
Asset Turnover Ratio (x)	0.83	0.81	0.57	0.52	0.55
Price to Earnings (x)	12.61	10.38	-18.98	-6.00	38.46
Price to Book (x)	2.25	2.20	1.51	0.98	1.59
EV/EBITDA (x)	7.99	6.84	12.87	18.12	11.43
EBITDA Margin (%)	23.26	25.90	11.71	7.32	17.46

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	15.20	17.79	-5.96	-17.22	7.63
Return on Capital Employed (%)	20.34	20.89	5.31	4.84	11.36
Return on Assets (%)	9.85	10.86	-3.31	-8.65	4.24
Interest Coverage Ratio (x)	9.99	7.87	2.65	2.21	4.85
Asset Turnover Ratio (x)	0.71	0.73	0.50	0.48	0.56
Price to Earnings (x)	14.25	11.81	-23.36	-5.36	19.65
Price to Book (x)	2.16	2.10	1.39	0.92	1.50
EV/EBITDA (x)	8.77	7.56	11.36	10.62	9.57
EBITDA Margin (%)	25.47	25.96	14.69	14.09	21.51

Insights

ROE Outperforming 5 Year Average
Company delivered ROE of 17.86% in year ending Mar 31, 2026 outperforming its 5 year avg. of 5.18%. (Source: Consolidated Financials)

Found Financials useful?

5 Days	14 Days	28 Days
-	-	-

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Fermenta Biotech	13.89	2.52	17.86	22.88	11.20	15.11	19.13	13.37	24.70	1.86	0.27	1.17
Syncom Form	17.19	3.17	18.41	23.76	14.31	29.31	20.90	15.62	0.81	3.18	0.00	0.03
Lincoln Pharma	14.06	1.63	11.60	14.96	9.87	9.66	17.38	13.09	43.88	5.25	0.01	0.04
Themis Medicare	944.91	2.71	0.28	-0.13	0.19	-1.30	-0.16	-3.77	0.12	1.84	0.25	-30.65
Bajaj Healthcare	67.84	2.01	2.95	14.28	1.70	-2.86	13.81	2.58	4.98	1.92	0.44	4.02
Add More

Annual Ratios (%)

Choose from Peers

Kopran Ltd
Wanbury Ltd
Anuh Pharma
Zim Laboratories
Kilitch Drug

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

NAME	1D	1W	1M	3M	1Y	3Y	5Y
Fermenta Biotech Stock Performance	1.61	17.53	8.50	0.00	0.00	0.00	0.00
Syncom Form Stock Performance	-0.08	1.23	2.42	6.55	-30.13	115.08	0.00
Lincoln Pharma Stock Performance	0.37	-7.38	1.44	-0.92	1.87	39.81	88.45
Themis Medicare Stock Performance	15.37	18.33	27.26	29.52	-17.55	-25.32	137.14
Bajaj Healthcare Stock Performance	1.54	8.21	-3.29	-9.87	-43.47	4.23	0.00
Add More

Category	No. of Shares	Percentage
Promoters	1,88,61,009	64.09 %
Pledge	0	0.00 %
FII	7,298	0.02 %
DII	419	0.00 %
MF	419	0.00 %
Others	1,05,62,261	35.89 %

Category	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Promoters	64.09	64.09	64.09	64.09
Pledge	0.00	0.00	0.00	0.00
FII	0.02	0.02	0.02	0.02
DII	0.00	0.00	0.00	0.00
Mutual Funds	0.00	0.00	0.00	0.00
Others	35.89	35.89	35.89	35.89

Mutual Funds Ownership

MF Ownership as on 31 May 2026

Motilal Oswal BSE Healthcare ETF-G
Equity: Sectoral-Pharma
- 0.01
  Amount Invested (in Cr.)
- 0.02%
  % of AUM
- -9.66
  % Change (MoM basis)
Bandhan BSE Healthcare Index Direct-G
Equity: Sectoral-Pharma
- 0.00
  Amount Invested (in Cr.)
- 0.02%
  % of AUM
- 7.20
  % Change (MoM basis)

View all Mutual Fund Schemes

Corporate Actions

Recent
General Meeting
-
May 26, 2026
Final
75%
May 26, 2026
Board Meeting
Audited Results & Final Dividend
May 19, 2026

Board Meetings

Announced on	Meeting on
May 19, 2026	May 26, 2026
Audited Results & Final Dividend
Feb 02, 2026	Feb 09, 2026
Quarterly Results
Oct 29, 2025	Nov 11, 2025
Quarterly Results
Aug 05, 2025	Aug 12, 2025
Quarterly Results
May 21, 2025	May 28, 2025
Audited Results, Final Dividend & ESOP

Dividends
Announced on Ex-Date Dividend%
May 28, 2025 Aug 06, 2025 50%
May 27, 2024 Aug 06, 2024 25%
May 29, 2023 Sep 22, 2023 25%
May 20, 2022 Aug 04, 2022 25%
May 26, 2026 - 75%

Announced on	Ex-Date	Dividend%
May 28, 2025	Aug 06, 2025	50%
May 27, 2024	Aug 06, 2024	25%
May 29, 2023	Sep 22, 2023	25%
May 20, 2022	Aug 04, 2022	25%
May 26, 2026	-	75%

Bonus

Announced on	Ex-Date
Dec 24, 2019	Feb 13, 2020
Bonus Ratio: 2 share(s) for every 1 shares held
Jun 18, 2018	Aug 08, 2018
Bonus Ratio: 1 share(s) for every 1 shares held
Sep 11, 1988	-
Bonus Ratio: 1 share(s) for every 3 shares held
Sep 11, 1984	-
Bonus Ratio: 1 share(s) for every 2 shares held

Splits
Announced on Ex-Date
Jun 18, 2018 Aug 08, 2018
Split: Old FV10.0| New FV:5.0
Rights
Announced on Ex-Date
Mar 24, 1995 Apr 03, 1995
Rights ratio: 1 share for every 6 held at a price of Rs 55.0
AGM/EGM Meetings
Announced on Meeting on
May 26, 2026 Aug 11, 2026
-
May 28, 2025 Aug 12, 2025
-
Apr 02, 2025 May 04, 2025
-
Nov 26, 2024 Dec 28, 2024
-
May 27, 2024 Aug 12, 2024
-

Announced on	Ex-Date
Jun 18, 2018	Aug 08, 2018
Split: Old FV10.0\| New FV:5.0

Announced on	Ex-Date
Mar 24, 1995	Apr 03, 1995
Rights ratio: 1 share for every 6 held at a price of Rs 55.0

Announced on	Meeting on
May 26, 2026	Aug 11, 2026
-
May 28, 2025	Aug 12, 2025
-
Apr 02, 2025	May 04, 2025
-
Nov 26, 2024	Dec 28, 2024
-
May 27, 2024	Aug 12, 2024
-

About Fermenta Biotech

Fermenta Biotech Ltd., incorporated in the year 1951, is a Small Cap company (having a market cap of Rs 1,008.31 Crore) operating in Pharmaceuticals sector.

Fermenta Biotech Ltd. key Products/Revenue Segments include Pharmaceuticals, Property Development, Service Income, Sale of services, Rent, Export Incentives, Other Operating Revenue and Scrap for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Consolidated Total Income of Rs 126.65 Crore, down 9.85 % from last quarter Total Income of Rs 140.48 Crore and down 11.89 % from last year same quarter Total Income of Rs 143.74 Crore. Company has reported net profit after tax of Rs 18.60 Crore in latest quarter.

The company’s top management includes Mr.Pradeep M Chandan, Mr.Krishna Datla, Mr.Prashant Nagre, Ms.Anupama Datla Desai, Mr.Satish Varma, Ms.Rajeshwari Datla, Mr.Pramod Kasat, Ms.Rajashri Ojha, Mr.Ramanand Mundkur, Mr.Sumesh Gandhi, Mr.Varadvinayak Khambete. Company has Deloitte Haskins & Sells LLP as its auditors. As on 31-03-2026, the company has a total of 2.94 Crore shares outstanding.

Fermenta Biotech Share Price Today is Rs. 342.60. On previous day, the Fermenta Biotech Share Price (NSE) closed at Rs. 318.8, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 64.09% of the stake in Fermenta Biotech shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Fermenta Biotech stocks was 0.02% as compared to 0.02% in Dec 2025 with decrease of 0.0%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 0.0% as compared to 0.0% in Dec 2025 with decrease of 0.0%. Out of the total DII holdings in Fermenta Biotech shares 0.0% was held by mutual funds. The rest including public held is 35.89%. Fermenta Biotech stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Fermenta Biotech Dividend: Ever since 1951, Fermenta Biotech dividends has been paid out around 34 times. As on 22 Jun, 2026, 03:46 PM IST, The overall dividend yield for Fermenta Biotech stands at 1.11%. The last dividend paid was on null (Rs. 3.75). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. 24.66.

Fermenta Biotech Bonus: The most recent bonus issue had been in year February 13, 2020 around 6 years ago at 1 : 2 ratio. The first bonus issue was announced in Sep 1984.

Stock Forecast:
After showing 126.65 Cr. of sales and 9.85% of quarterly net loss, there have been multiple ups and downs in the Fermenta Biotech stock prices in the past few weeks. For example, Fermenta Biotech stock price on 12th of June 2026 was around Rs. 338.35. Fermenta Biotech share price now stands at an average of Rs. 342.60. Judging by last week's performance, stock is in down trend.

Fermenta Biotech has a median target price of Rs. 0.0 in 12 months by 0 analysts. They have provided a high estimate of Rs. 0.0 and low estimate of Rs. 0.0 for Fermenta Biotech share.

Historical Prices and Performance:
Fermenta Biotech, incorporated in 1951 is a Small Cap company (with a market cap of Rs. 992.41) operating in Pharmaceuticals sector.
The Return of Equity (ROE) in last five financial years given by Fermenta Biotech stock was 17.86%, 21.19%, -7.98%, -16.36% and 4.15% respectively.
The Fermenta Biotech share gave a 3 year return of 109.66% as compared to Nifty 50 which gave a return of 38.24%.
Fermenta Biotech announced 75.0% final dividend on null.

Key Metrics:
PE Ratio of Fermenta Biotech is 13.67
Prices/Sales Ratio of Fermenta Biotech is 1.74
Price/Book Ratio of Fermenta Biotech is 2.48

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For Fermenta Biotech, major competitors and peers include Syncom Form, Lincoln Pharma, Bajaj Healthcare and Themis Medicare. As of Dec 2025, the dividend yield of Fermenta Biotech stands at 1.11% while Syncom Form, Lincoln Pharma, Bajaj Healthcare and Themis Medicare stand at 0.0%, 0.0%, 0.48% and 0.0% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at 13.67 and 2.48 respectively.

Leadership of Fermenta Biotech :
Varadvinayak Khambete is Co. Secretary & Compl. Officer
Sumesh Gandhi is Chief Financial Officer
Pradeep M Chandan is Chairman & Ind.Dire (Non-Exe)
Krishna Datla is Exe.Vice Chairman & Whole Time Director
Prashant Nagre is Managing Director
Satish Varma is Executive Director
Anupama Datla Desai is Executive Director
Rajeshwari Datla is Non Executive Director
Pramod Kasat is Ind. Non-Executive Director
Rajashri Ojha is Ind. Non-Executive Director
Ramanand Mundkur is Independent Director

Industry

Pharma - Indian

Key Indices Listed On

BSE Healthcare, BSE AllCap

Address

A-1501, Thane One,DIL Complex,Ghodbunder Road,Thane, Maharashtra - 400610

Contact

info@fermentabiotech.com

https://www.fermentabiotech.com

PE Ratio(x)	13.89
EPS - TTM(₹)	24.66
MCap(₹ Cr.)	1,008.31
MCap Rank	90
PB Ratio(x)	2.48
Div Yield(%)	1.09
Face Value(₹)	5.00
52W High(₹)	356.85
52W Low(₹)	248.85
MCap/Sales	1.74
Beta(1 Month)	-
BV/Share(₹)	136.10

PE Ratio(x)	13.87
EPS - TTM(₹)	24.66
MCap(₹ Cr.)	1,006.54
MCap Rank	91
PB Ratio(x)	2.49
Div Yield(%)	1.10
Face Value(₹)	5.00
52W High(₹)	399.00
52W Low(₹)	256.40
MCap/Sales	1.74
Beta(1 Month)	2.82
BV/Share(₹)	136.10

1 Day	1.61%
1 Month	13.65%
3 Months	N.A.
1 Year	N.A.
3 Years	N.A.
5 Years	N.A.

1 Day	1.12%
1 Month	13.0%
3 Months	-2.88%
1 Year	8.47%
3 Years	154.09%
5 Years	5.34%

R1	-	Pivot -	S1	-
R2	-		S2	-
R3	-		S3	-

Fermenta Biotech Share Price

Key Metrics